非手术鼻整形注射后视力丧失:病例系统综述与管理
该系统综述汇总了22例鼻部填充注射后视力丧失病例,平均年龄33.4岁,90.9%为女性,50%使用透明质酸。82%视力丧失在注射后立即发生,鼻背/鼻根是最常见注射部位(57%)。仅27%完全恢复视力,平均需5.3个月,透明质酸酶、皮质类固醇和抗生素治疗常无法逆转,高压氧治疗显示潜力。
要点
- 鼻背/鼻根注射是最常见视力丧失部位,占57%。
- 82%病例视力丧失在注射后立即发生,仅27%完全恢复。
- 透明质酸酶、皮质类固醇和抗生素治疗常无法逆转视力丧失。
核心结论
- 鼻部填充注射后视力丧失罕见但灾难性,常立即发生且不可逆。
- 仅27%病例完全恢复视力,平均恢复时间5.3个月。
- 高压氧治疗显示潜力,需进一步研究。
研究设计与样本
- 系统综述,检索Scopus、Ovid Medline和CINAHL,筛选1498篇唯一文献。
- 三位评审独立提取数据,采用描述性统计总结。
主要发现
- 患者平均年龄33.4岁,90.9%为女性。
- 透明质酸是最常用填充剂,占50%。
- 82%病例视力丧失在注射后立即发生。
- 注射部位报告18例(86%),其中5例(24%)多部位注射。
- 鼻背/鼻根最常见(12例,57%),其次眉间区(6例,29%)。
关键数值与推荐
- 完全视力恢复仅27%病例,平均需5.3个月。
- 透明质酸酶、皮质类固醇和抗生素治疗常无法逆转视力丧失。
临床怎么用
- 强调通过细致技术、详细解剖知识和及时干预进行预防。
- 高压氧治疗可作为潜在干预手段,但需进一步研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Vision loss following nonsurgical rhinoplasty with dermal fillers is a rare but catastrophic complication. This systematic review synthesizes reported cases of visual impairment after nasal filler injection, focusing on mechanisms of injury, risk factors, management strategies, and outcomes. A systematic search of Scopus, Ovid Medline, and CINAHL was performed using terms related to visual changes, dermal fillers, and nonsurgical rhinoplasty. After duplicate removal, 1,498 unique articles were screened using predefined inclusion and exclusion criteria. Data were extracted independently by three reviewers, and descriptive statistics summarized patient demographics, injection sites, filler types, treatments, and outcomes. Twenty-one articles met inclusion criteria, comprising 22 cases of vision loss. The mean patient age was 33.4 years, and 90.9% of patients were female. Hyaluronic acid was the most commonly used filler (50%). Vision loss occurred immediately after injection in 82% of cases. Injection site was reported for 18 patients (86%), with 5 patients (24%) receiving injections in multiple locations. The nasal bridge or dorsum was the most frequent injection site (12 patients, 57%), followed by the glabellar region (6 patients, 29%). Full visual recovery occurred in only 27% of cases, requiring an average of 5.3 months. Vision loss was often immediate and irreversible despite treatment with hyaluronidase, corticosteroids, and antibiotics. Hyperbaric oxygen therapy showed promise and warrants further study. Prevention through careful technique, detailed anatomical knowledge, and prompt intervention remains essential.
引用
- Pistone ES, Patel MM, Brondeel K, et al. Vision Loss Following Nonsurgical Rhinoplasty Injections: Systematic Review of Cases and Management. Aesthet Surg J. 2026. PMID: 42660550. doi:10.1093/asj/sjag174
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。